TrialBMJ (Clinical research ed.)2015

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial.

Noortje van Herwaarden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.